Samsung Biologics Co Ltd
KRX:207940
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Samsung Biologics Co Ltd
KRX:207940
|
KR |
|
V
|
Vardhman Textiles Ltd
BSE:502986
|
IN |
|
N
|
NXP Semiconductors NV
SWB:VNX
|
NL |
|
G
|
Grupo Aeroportuario del Centro Norte SAB De CV
SWB:G7A
|
MX |
|
E
|
Element Solutions Inc
F:PLQ
|
US |
|
X
|
Xiabuxiabu Catering Management (China) Holdings Co Ltd
F:0XI
|
CN |
|
C
|
CDL Hospitality Trusts
SGX:J85
|
SG |
|
National Bank of Canada
TSX:NA
|
CA |
|
Amcor PLC
OTC:AMCCF
|
UK |
|
Netscout Systems Inc
NASDAQ:NTCT
|
US |
|
A
|
AXA SA
F:AXAA
|
FR |
|
D
|
Dermapharm Holding SE
XHAM:DMP
|
DE |
|
Delivery Hero SE
XETRA:DHER
|
DE |
|
Beam Therapeutics Inc
NASDAQ:BEAM
|
US |
|
A
|
Alaska Air Group Inc
SWB:ALK
|
US |
|
Prysmian SpA
F:AEU
|
IT |
|
M/I Homes Inc
NYSE:MHO
|
US |
|
FirstRand Ltd
F:FSR
|
ZA |
|
I
|
Impala Platinum Holdings Ltd
JSE:IMP
|
ZA |
Bankruptcy Probability
Samsung Biologics Co Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Samsung Biologics Co Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
65.4T KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
357.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Baxter International Inc
NYSE:BAX
|
12.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
224.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
141B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
461B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
37.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
42.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
40.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Samsung Biologics Co Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Samsung Biologics Co Ltd has total debt of 881B KRW. This includes both short-term (46.2B KRW) and long-term (834.7B KRW) debt.
You can find a full breakdown on its Balance Sheet.
